Ken ,
Here is a newsletter writers opinion of the takeover:
His currency conversions are inaccurate (CDN $ would be greater than expressed). I own IMM and all I can say is it is about time
----------------------------------------------------------------------------------------------------
Emerging Growth Stocks Corporate Update
February 11, 1997
Please Read our Disclaimer at the bottom if you have not already done so.
IMMUNE NETWORK RESEARCH TO BE ACQUIRED
IMM is halted today to disseminate the news that a new agreement has been struck with Bio-Fluorescent Technologies of Nevada (new trading symbol - BFTK on the OTC-BB) whereby BFTK will acquire IMM for 9 million shares of BFTK. IMM closed yesterday at $0.16 (CDN), and BFTK at $0.34 (US). This news was announced very late in the day, well after the close of trading, and therefore did not have an effect on trading in either stock. The takeover is subject to exchange and shareholder approvals, and is expected to be wrapped up by May at the latest.
You may recall, this was the same company that attempted to merge with IMM in October, but the VSE kiboshed the deal for one reason or another. My guess is, this time it will be allowed, because IMM shareholders can only benefit from the takeover. Let's examine the transaction to see why.
It looks like current IMM shareholders will receive one share of BFTK for every two shares of IMM they hold. At todays price of $0.37 US, converted to CDN that's about $0.46 CND, divided by two, this makes our IMM shares worth about $0.23, a nice increase from the current price. But look closer. In October BFTK was rolled back 1 for 3, leaving a mere 6 million shares outstanding. They rolled it back for a reason, the same reason any company does it - to move the stock up and do some financing. Upon the rollback, the stock traded around $0.75, and has since drifted down to the current low level. Once the dust settles however, I would expect the stock to be promoted to a higher level. My target would be US $0.80 to $1.00. Call it US $0.90. That makes our IMM shares worth about US $0.45, or about CND $0.57. This is all theoretical, I admit to reaching a bit here, but I believe, well within the realm of possibility.
A shareholders meeting should be called shortly, and I see no reason not to vote a resounding yes for this takeover.
I expect IMM to remain halted for at least the next few days while some administrative details related to the transaction get completed.
Louis Paquette
Author and Publisher,
EMERGING GROWTH STOCKS
102-2020 Comox St., Vancouver, B.C. V6G 1R9
Phone/Fax : (604) 687-5772, E-mail: 28212@msn.com
www.info-mine.com/egs
www.stockhouse.com
DISLAIMER -
Louis Paquette`s Emerging Growth Stocks is an independant publication committed to providing an objective analysis of the markets, focusing on the VSE, and individual companies with substantial upside potential over the next six to twelve months. The information contained herein is believed to be accurate but this cannot be guaranteed. The analysis does not purport to be a complete study of securities mentioned herein, and readers are advised to discuss any related purchase or sale decisions with a registered securities broker. Companies featured in EGS are often at very early stages of development and can therefore subject to business failure, and are to be considered speculative and high risk in nature. Reports herein are for information purposes and are not solicitations to buy or sell any of the securities mentioned. The author may or may not hold a positon (long or short) in the securities mentioned herein, This publication may not be reproduced without the expressed prior consent of the author.
------------------------------------------------------------------------
c 1997 StockHouse Online Journal | Disclaimer
Top | StockHouse Front Page | Emerging Growth Stocks Menu
---------------------------------------------------------------------------
Dan Byrne |
